M NEXUS INSIGHT
// technology

How long do you take Phesgo?

By Matthew Wilson

How long do you take Phesgo?

PHESGO is given every 3 weeks until the cancer progresses or side effects become too difficult to manage.

Is Herceptin and Perjeta considered chemotherapy?

Perjeta (chemical name: pertuzumab) used in combination with Herceptin (chemical name: trastuzumab), another targeted therapy medicine, and Taxotere (chemical name: docetaxel), a type of chemotherapy, to treat HER2-positive, metastatic breast cancer that hasn’t been treated with either Herceptin or chemotherapy yet.

Is Kanjinti chemotherapy?

Kanjinti is a cancer medicine used to treat the following conditions: • early breast cancer (when the cancer has spread within the breast or to the glands under the arm but not to other parts of the body) after surgery, chemotherapy (medicines to treat cancer), and radiotherapy (treatment with radiation) if applicable.

How effective is perjeta?

94.1% of the women in the Perjeta treatment group were alive with no cancer recurrence. 93.2% of the women in the standard treatment group were alive with no cancer recurrence.

Is Phesgo chemo?

For early-stage or inflammatory HER2-positive breast cancer, Phesgo is prescribed with chemotherapy. Depending on the chemotherapy regimen you’ve been prescribed, you may get Phesgo either before or after chemotherapy.

How much does Phesgo cost?

The cost for Phesgo subcutaneous solution (20,000 units-600 mg-600 mg/10 mL) is around $8,853 for a supply of 10 milliliters, depending on the pharmacy you visit….Subcutaneous Solution.

QuantityPer unitPrice
10 milliliters$885.32$8,853.22

Do you lose your hair with perjeta?

Pertuzumab and trastuzumab do not usually cause people to lose their hair. Any hair loss caused by chemotherapy should be temporary and in most cases your hair will begin to grow back once your chemotherapy has ended.

Is Kanjinti as good as Herceptin?

KANJINTI was proven to be highly similar to, and to have no clinically meaningful differences from, Herceptin based on a comprehensive totality of evidence which included extensive comparative analytical, pharmacokinetic and clinical data.

What is the difference between Kanjinti and Herceptin?

Additional information: Kanjinti is a biosimilar of Herceptin. Herceptin is a monoclonal antibody, “biologic” drug. This means that it is made from living organisms, in this case a protein from a mouse cell.

Do you lose your hair with PERJETA?

Is PERJETA considered chemotherapy?

Drug Type: Perjeta™ is an anti-cancer (“antineoplastic” or “cytotoxic”) chemotherapy drug. This medication is classified as an “antineoplastic agent and a monoclonal antibody”.